These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. A long-term evaluation of pargyline hydrochloride in hypertension. Esbenshade JH; Fewell JW; Frankl WS; Sutnick AI; Turner LW Am J Med Sci; 1966 Jan; 251(1):81-5. PubMed ID: 5322074 [No Abstract] [Full Text] [Related]
47. [Treatment of arterial hypertension with guanethidine, 1-alpha-methyldopa and pargyline hydrochloride]. Montoreano F; Abrahim H; Plotquin J Prensa Med Argent; 1966 Jun; 53(22):1248-51. PubMed ID: 5968337 [No Abstract] [Full Text] [Related]
48. [Pargyline hydrochloride, a new antihypertensive drug]. Stroescu V Med Interna (Bucur); 1966 Oct; 18(10):1263-6. PubMed ID: 5978455 [No Abstract] [Full Text] [Related]
49. [Methylclothiazide in arterial hypertension]. Nogueira WP; D'Andrea I; Nakaguma H; Correia LA Rev Bras Med; 1969 Feb; 26(2):131-3. PubMed ID: 5790653 [No Abstract] [Full Text] [Related]
50. Influence of dosage and duration of therapy on the rate of response to methyclothiazide in essential hypertension. Soghikian K; Bartenbach DE South Med J; 1977 Dec; 70(12):1397-404. PubMed ID: 594788 [TBL] [Abstract][Full Text] [Related]
51. The effects of terazosin and methyclothiazide on blood pressure and serum lipids. Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723 [TBL] [Abstract][Full Text] [Related]
52. [Clinical and renal hemodynamic effects of pargyline]. Pupita F; Bartoli E; Colongo PG; Brusasco L Clin Ter; 1967 Mar; 40(5):439-46. PubMed ID: 5601187 [No Abstract] [Full Text] [Related]
53. Effect of pargyline on blood pressure and mood of hypertensive patients. Beato V; Duarte R; Alvarez del Puerto H Curr Ther Res Clin Exp; 1966 Nov; 8(11):515-22. PubMed ID: 4963158 [No Abstract] [Full Text] [Related]
54. [Treatment of arterial hypertension with pargyline chlorhydrate]. Purriel P; Castro Bianchino O Torax; 1965 Jun; 14(2):143-6. PubMed ID: 5881278 [No Abstract] [Full Text] [Related]
55. Cryptenamine-based mixtures for chronic therapy of benign arterial hypertension. Cohen BM Curr Ther Res Clin Exp; 1966 Sep; 8(9):424-34. PubMed ID: 4957928 [No Abstract] [Full Text] [Related]
56. [Clinical and biological effects of methyclothiazide (Enduron). (Apropos of 30 cases)]. de Grailly R; Leuret JP J Med Bord; 1966 Aug; 143(8):1147-55. PubMed ID: 5954815 [No Abstract] [Full Text] [Related]
57. [Methyclothiazide in the therapy of patients with heart insufficiency]. Flensted-Jensen E Ugeskr Laeger; 1968 Feb; 130(7):278-81. PubMed ID: 5676614 [No Abstract] [Full Text] [Related]
58. [Clinical use of sulfamide diuretic: methyclothiazide]. Hertault J Sem Ther; 1964 Nov; 40(9):573-5. PubMed ID: 5878674 [No Abstract] [Full Text] [Related]
59. Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism. Parfitt AM Ann Intern Med; 1972 Oct; 77(4):557-63. PubMed ID: 4642736 [No Abstract] [Full Text] [Related]
60. Pargyline-induced mania in primary affective disorder: case report. Folks D; Arnold ES J Clin Psychiatry; 1983 Jan; 44(1):25-6. PubMed ID: 6822482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]